Gland Pharma Ltd News

Glenmark, Biocon, Aurobindo slip 3% on Trump's generic drug tariff plan

The US President Donald Trump announced a proposal to impose phased tariff (up to 200%) regime on imported generic medicines aimed at encouraging pharmaceutical manufacturing within the United States.

Nifty Midcap 100, Smallcap 100 indices down nearly 1% in firm market

At 01:59 PM on Friday, the Nifty Midcap 100 and Nifty Smallcap 100 indices were down 0.6 per cent each, as against 0.7 per cent rise in the Nifty 50 index.

HDFC Securities analyst flags key support levels for Nifty; 2 stocks to buy

Gland Pharma has given a breakout from a bullish 'Inverted head and shoulder' pattern, and Viyash Scientific from bullish 'Cup and handle pattern', says Vinay Rajani of HDFC Securities.

Nifty Pharma extends rally, up 2%; Piramal Pharma, Laurus gain up to 10%

Analysts said that a combination of defensive buying, strong earnings visibility, export tailwinds, and sector rotation is driving the rally in pharma stocks.

Adani Ent, Bajaj Auto, Voda Idea, 16 more BSE 500 stocks hit 52-week highs

Hindalco, KEI Industries, Polycab, Apollo Hospital, Anand Rathi Wealth, GE Vernova T&D, Manappuram Finance, Navin Flurochemicals, Torrent Pharma and J B Chemicals hit fresh life-time highs on Monday.

Gland Pharma shares jump 16% to 52-week high on Q4; analysts retain 'Buy'

Sentiment was further buoyed by bullish brokerage commentary, with Elara Capital and Motilal Oswal Financial Services retaining Buy calls on Gland Pharma, citing strong earnings

Sun Pharma, Dr Reddy's Labs, Onesource: Nifty Pharma rallies 3%; details

Among others, Sun Pharma was the top gainer up over 7 per cent, followed by Gland Pharma, Alkem Laboratories, Zydus Lifesciences and Wockhardt up over 2 per cent

Gland Pharma jumps 9% to over 2-month high on strong Q3FY26 results

The share price rose as much as 9.32 per cent to ₹1,847.10, the highest level since November 14, 2025 on the National Stock Exchange (NSE)